Brice Tiret1,2, Maria-Angeles Carrillo-de Sauvage1,2, Huu Phuc Nguyen3,4, Nicole El Massioui5,6, Valérie Doyère5,6, Vincent Lebon1,2, Emmanuel Brouillet1,2, and Julien Valette1,2
1CEA/DSV/I2BM/MIRCen, Fontenay-aux-Roses, France, 2CNRS Université Paris-Saclay UMR 9199, Fontenay-aux-Roses, France, 3Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany, 4Centre for Rare Diseases, University of Tuebingen, Tuebingen, Germany, 5Paris-Saclay Institute of Neuroscience, Université Paris-Sud, UMR 9197, Orsay, France, 6Centre National de la Recherche Scientifique, Orsay, France
Synopsis
Localized 31P
MRS with progressive magnetization transfer (MT) is performed in the BACHD
transgenic rat model of Huntington’s disease to assess energy metabolism.
Localized measurements of the ATP formation rate through creatine kinase and oxidative
phosphorylation (ATPsynthase) are performed in the rat brain for the first
time. Results show that ATPsynthase rate is reduced by a factor 2, which is
partly compensated by higher cerebral concentrations of phosphocreatine to
generate ATP via creatine kinase.TARGET AUDIENCE:
Those interested in
31P
MRS, energy metabolism and Huntington’s disease.
Purpose:
In this work we use
localized
31P MRS, including progressive magnetization transfer (MT)
experiments, to assess energy metabolism in a transgenic rat model of
Huntington’s disease (BACHD [1]). Localized measurements
of the ATP formation rate through creatine kinase and ATPsynthase are performed
in the rat brain for the first time, and reveal an altered metabolic status in
BACHD rats.
Methods:
Animal preparation and in vivo 31P MRS: Seven
18 to 24 months old transgenic rats (BACHD) and six age-matched wild type (WT) littermates
anesthetised with 1.5-2 % isoflurane were used to estimate forward reaction
rates of both ATP synthase (kf-ATPase) and creatine kinase (kf-CK)
using 31P magnetization transfer MRS [2]. All
measurements were performed using a 11.7T Bruker BioSpec using a 1.5-cm double-tuned
surface coil (Rapid Biomed GmbH®). Localisation of a large 11×8×12 mm (Fig. 1)
voxel was achieved using an adiabatic ISIS module followed by a selective
BISTRO progressive saturation of the γ-ATP peak. We decided to quantify peak
(PCr and Pi) attenuation relative to an unsaturated spectrum rather than
symmetric saturation, because: i) signal loss due to RF bleed-over was minimal (~5%)
during selective symmetric saturation, as assessed on preliminary experiments (Fig. 2A); and ii)
possible residual bias would be identical in both groups and thus wouldn’t
affect intergroup comparison. Three different saturation times (tsat=0.55, 1.1 and 2.2 s, Fig. 2B) were used for
γ-ATP saturation, as well as two unsaturated spectra, one acquired at the
beginning and one at the end of each acquisition, which also ensured that
signal remained stable throughout the experiment. Each spectrum was acquired in
17 min, making it possible to estimate kf-CK at the individual level
in less than 2 hours (including animal preparation) given the fact that
symmetric-saturation spectra needed not to be acquired. Due to lower signal to
noise ratio on the Pi peak, kf-ATPase was estimated only at group
level, with Pi being quantified on spectra averaged over all animals
of each group.
Data Analysis:
Data were analysed with LCModel using a simulated basis set, and metabolite
concentrations were estimated in both groups on unsaturated spectra. PCr
concentration was estimated relative to α-ATP concentration which was
considered constant (and indeed yielded the same absolute signal on spectra in
both groups, see Fig. 3).
From the chemical shift difference between Pi and PCr, the pH was also derived.
Individual concentrations of PCr, and group concentrations of Pi, were fitted
as a non-linear function of saturation time according to modified Bloch
equations accounting for chemical exchange. The standard deviation for kf-ATPase
was derived from Monte Carlo simulations over 500 repetitions.
Results
and Discussion:
The concentration of phosphocreatine
(PCr/α-ATP) exhibits a moderate but significant 10% increase in the BACHD group
compared to the WT group (1.84±0.15 vs. 1.67±0.11, p=0.026) (
Fig. 3).
Note that such an increase has also been reported during healthy aging [3]. No pH
difference was found, contrasting with our previous results in 3NP-treated rats
and Human patients [4], and suggesting
a milder disease or a specific metabolic adaptation. There was no difference in
k
f-CK (0.43±0.07 s-1 vs. 0.44±0.10 s-1 BACHD
vs. WT) between the two groups (
Fig. 4A). However,
considering the increased PCr levels, the total flux of ATP generation through creatine
kinase ([PCr]*k
f-CK) is increasing by ~10%. In parallel, a large decrease
was measured for k
f-ATPase (0.23±0.02 s-1 vs. 0.48±0.10 s-1
BACHD vs. WT, p=0.05 based on permutation test on the
distribution generated by Monte Carlo simulations) (
Fig. 4B). Altogether these
results suggest an adaptive mechanism in the transgenic rat model involving a larger
PCr pool to compensate for the defect in oxidative phosphorylation reflected by
k
f-ATPase.
Conclusion:
We demonstrate for the
first time the use of localised
31P MT-MRS to quantify both k
f-CK
and k
f-ATPase in the rat brain. This study also points towards a
mitochondrial deficit in the BACHD rat model that can be quantified by
31P
MT-MRS, with ATP synthase rate reduced by a factor 2. This decrease could be partly
compensated by higher cerebral concentrations of phosphocreatine (the origin of
which remains to be elucidated, but could be related to peripheral PCr
formation) as a readily available energy source.
Acknowledgements
This project was funded by the French National
Research Agency (ANR-14-CE15-0007, HDeNERGY project).References
[1] Yu-Taeger L, Petrasch-Parwez E, Osmand
AP, Redensek A, Metzger S, Clemens LE, Park L, Howland D, Calaminus C, Gu X,
Pichler B, Yang XW, Riess O, and Nguyen HP, “A novel BACHD transgenic rat
exhibits characteristic neuropathological features of Huntington disease,” J
Neurosci, vol. 32, no. 44, pp. 15426–38, 2012.
[2] H.
Lei, K. Ugurbil, and W. Chen, “Measurement of unidirectional Pi to ATP flux in
human visual cortex at 7 T by using in vivo 31P magnetic resonance
spectroscopy.,” Proc. Natl. Acad. Sci. U. S. A., vol. 100, no. 24, pp.
14409–14, 2003.
[3] R.
Longo, C. Ricci, L. Dalla Palma, R. Vidimari, a Giorgini, J. a den Hollander,
and C. M. Segebarth, “Quantitative 31P MRS of the normal adult human brain.
Assessment of interindividual differences and ageing effects.,” NMR Biomed.,
vol. 6, no. 1, pp. 53–7, 1993.
[4] M.
M. Chaumeil, J. Valette, C. Baligand, E. Brouillet, P. Hantraye, G. Bloch, V.
Gaura, A. Rialland, P. Krystkowiak, C. Verny, P. Damier, P. Remy, A.-C.
Bachoud-Levi, P. Carlier, and V. Lebon, “pH as a biomarker of neurodegeneration
in Huntington’s disease: a translational rodent-human MRS study,” Journal of
Cerebral Blood Flow & Metabolism, vol. 32. pp. 771–779, 2012.